PT-141 10 mg
Description
PT141 10 MG
PT-141 (Bremelanotide) — Research Grade Peptide
Overview
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide research reagent that functions as a melanocortin receptor agonist and is used to investigate central neuroendocrine pathways. Supplied as a lyophilized peptide for stability and analytical precision; QC verified for sequence fidelity and batch purity.
Research context
Research context Intended for non-clinical laboratory studies, PT-141 is used to probe melanocortin receptor (MC1R/MC3R/MC4R) pharmacology, hypothalamic and limbic pathway modulation for in-vitro and ex-vivo, and receptor binding / signaling mechanism studies in controlled research settings.
Product Information
- Product name PT-141 (Bremelanotide)
- FormulaC50H68N14O10
- Molecular weight~1025.2 g/mol
- CAS number189691-06-3
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid
- Purity>99% (HPLC verified)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution and aseptic handling.
Research Applications
- In vitro receptor binding and signaling assays (MC4R/MC3R/MC1R).
- Neuroendocrine and hypothalamic pathway studies related to sexual behavior and arousal.
- Ex vivo tissue assays and receptor localization studies.
- Mechanistic combination studies with other neuromodulators in controlled laboratory experiments.
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
